Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of MDR-001 in Subjects Who Are Obesity or Overweight [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the efficacy and safety of MDR-001 in individuals who are obese or overweight; the study is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight

Drugs mentioned

• MDR-001

Snippet

Sponsor: MindRank AI Ltd | Conditions: Obesity, Overweight and Obesity | Phase 2 | Status: NOT_YET_RECRUITING